0.5800
30-January-25 16:45:00
15 minutes delayed
Stocks
+0.0498
+9.39%
Today's range
0.5210 - 0.5800
ISIN
N/A
Source
NASDAQ
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
25 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
28 May 2024 07:03:00 By Nasdaq GlobeNewswire